Bionano Genomics, Inc. is focused on providing optical genome mapping, solutions for genome analysis. The Company provides tools and services based primarily on its Saphyr system to scientists and clinicians conducting genetic research and patient testing. It also provides diagnostic testing services for pediatric patients suspected of neurodevelopmental disabilities. Its Saphyr system is a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to search for diagnostics and therapeutic targets and to streamline the identification of structural changes in chromosomes. The Saphyr system is consists of an instrument, chip consumables, reagents, and a suite of data analysis tools. It also provides proprietary molecular genetic diagnostic services for individuals demonstrating clinical presentations consistent with neurodevelopmental disorders, including autism spectrum disorders and other disorders of childhood development.
During the most recent quarter, 5K shares were bought in insider trading.
Insider trading information report provided by Copyright © 2022. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.